Belatacept and non-melanoma skin cancer risk in kidney transplant recipients: a narrative review from a mechanistic and clinical perspective

Belatacept and non-melanoma skin cancer risk in kidney transplant recipients: a narrative review from a mechanistic and clinical perspective

Abstract Non-melanoma skin cancer is a prevalent complication in renal transplant recipients due to long-term immunosuppressive therapy. Calcineurin inhibitors, such as tacrolimus and cyclosporine, are effective in preventing graft rejection; however, they significantly increase the risk of non-mela...

Full description

Saved in:
Bibliographic Details
Main Authors: Hany M. El Hennawy, Omar Safar, Ahmed Nassar, Mahmoud Z. El Madawie, Mohammad F. Zaitoun, Yasser M. Almahdi, Abdullah S. Al Faifi, Ibrahim Tawhari
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Nephrology
Subjects:
Belatacept
Non-melanoma skin cancer
Kidney transplant
Online Access:https://doi.org/10.1186/s12882-025-04373-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12882-025-04373-z

Similar Items